[Are fixed cervical lymph node metastases always inoperable?].

E Fossion; H Harris

PubMed · 6858536

[Are fixed cervical lymph node metastases always inoperable?].

Abstract

Between 1977 and 1980 22 head and neck patients with large fixed lymph node metastases were operated 3 to 8 weeks after preoperative radiotherapy to 60 Gray. Six tumor-free survivals of more than 3 years prove that the fixation of lymph nodes, though serious, does not automatically mean inoperability. When the primary tumor is under control, it is always worth while to explore the neck. The actual reconstruction of the soft tissue cover is no longer a problem. And since the carotid artery can either be ligated (under EEG control) or by-passed, the real danger comes from deep loco-regional invasion into the base of the skull, the intervertebral foramina and the suprahyoid muscles. A specialized and if necessary a polydisciplinary approach is advocated to give these patients a reasonable chance of operability with a quantitatively and qualitatively decent survival.

Explore related subjects

Head and Neck Neoplasms Humans Lymph Node Excision Lymphatic Metastasis Neck Dissection Patient Care Team Preoperative Care Prognosis English Abstract Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

E Fossion, H Harris. [Are fixed cervical lymph node metastases always inoperable?].. https://pubmed.ncbi.nlm.nih.gov/6858536/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

The value of sentinel lymph node biopsy in the management of head and neck melanoma.

Explore the source record for details and available documents.

Head and Neck Neoplasms↗

PubMed2007

Novel correction methods as alternatives for the six-dimensional correction in CyberKnife treatment.

PURPOSE: During CyberKnife treatment, the 6D correction method is used to correct patient positional errors, including rotational ones. We developed novel correction methods for translating rotational errors into 3D, with the aim of making their correction safer than with 6D correction and as accurate as possible. MATERIALS AND METHODS: These novel correction methods were named the gravity correction and the beam correction method. With the gravity correction method, the beam coordinates after rotation are corrected to match the tumor gravity point with 3D translational components translated by the affine transformation matrix. For beam correction, the beam coordinates are corrected to match the translated tumor target coordinates for each treatment beam. The effectiveness and impact of these methods were demonstrated by means of dose volume histogram (DVH) shift evaluation. For analysis of the treatment data of 10 patients, the treatment beam was rotated in three patterns of rotational degree and corrected with the two methods. The amount of tumor gravity point shift in the rotation was also calculated, and the deterioration of the tumor DVH was studied. RESULTS: In the case of +/-1 degrees , +/-3 degrees , and +/-1 degrees rotation for the X, Y, Z axes, the tumor gravity point of all 10 patients moved around 2.4 mm on average. Tumor DVH was deteriorated worse as the distance between the tumor gravity point and the rotational origin became more distant. With the planned D90, which represents the dose above which 90% of the tumor volume is irradiated set at 100%, the postrotational average D90 dose deteriorated to 96.12% after (+/-1 degrees , +/-3 degrees , and +/-1 degrees ) rotation. The dose was improved to 99.9% (SD +/- 0.41) after the gravity correction, or to 99.87% (SD +/- 0.55) after the beam correction. CONCLUSION: The correction methods developed by us can correct tumor DVH findings to the same degree as with 6D correction and are safer because the movement required for correcting the linac is not rotational but translational only.

Head and Neck Neoplasms↗

PubMed2007

Intensity-modulated radiation therapy in head and neck cancers: an update.

Intensity-modulated radiation therapy (IMRT), an advent of three-dimensional conformal radiotherapy (3D CRT), has excited the profession of radiation oncology more than any other new invention since the introduction of the linear accelerator. Approximately 1000 articles have been published on this topic to date, more than 200 of which focus on head and neck cancer. IMRT is based on computer-optimized treatment planning and a computer-controlled treatment delivery system. The computer-driven technology generates dose distributions that sharply conform to the tumor target while minimizing the dose delivered to the surrounding normal tissues. The high dose volume that tailors to the 3D configuration of the tumor along with the ability to spare the nearby normal tissues allows the option of tumor dose escalation. The head and neck region is an ideal target for this new technology for several reasons. First, IMRT offers the potential for improved tumor control through delivery of high doses to the target volume. Second, because of sharp dose gradients, IMRT results in the relative sparing of normal structures, such as the parotid glands, in the head and neck region. Third, organ motion is virtually absent in the head and neck region so, with proper immobilization, treatment can be accurately delivered. Although this is a relatively new technology, single-institution retrospective studies show better dosimetric profiles compared with conventional radiation techniques, as well as excellent clinical results. Salivary gland sparing using IMRT has also resulted in reduced incidence and severity of xerostomia, and this has been tested in a randomized trial against conventional radiotherapy for early-stage nasopharyngeal cancer. The results do confirm that IMRT does decrease xerostomia compared with conventional radiotherapy.

Head and Neck Neoplasms↗